Addex Therapeutics Ltd (ADXN) insider trading
Every open-market stock purchase and sale by Addex Therapeutics Ltd executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- No open-market insider buys on record.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $2.89 on Oct 22, 2026.
Recent ADXN insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 2, 2026 | Lenaic Nathanael Teyssedou (Officer) | Sold (not open market) | — |
| Sep 2, 2026 | Lenaic Nathanael Teyssedou (Officer) | Bought (not open market) | — |
| Sep 2, 2026 | Lenaic Nathanael Teyssedou (Officer) | Sold (not open market) | — |
| Sep 2, 2026 | Lenaic Nathanael Teyssedou (Officer) | Bought (not open market) | — |
| Sep 2, 2026 | Lenaic Nathanael Teyssedou (Officer) | Sold (not open market) | — |
| Sep 2, 2026 | Lenaic Nathanael Teyssedou (Officer) | Bought (not open market) | — |
| Sep 2, 2026 | Lenaic Nathanael Teyssedou (Officer) | Sold (not open market) | — |
| Sep 2, 2026 | Lenaic Nathanael Teyssedou (Officer) | Bought (not open market) | — |
| Sep 2, 2026 | Lenaic Nathanael Teyssedou (Officer) | Sold (not open market) | — |
| Sep 2, 2026 | Lenaic Nathanael Teyssedou (Officer) | Bought (not open market) | — |
| Sep 2, 2026 | Lenaic Nathanael Teyssedou (Officer) | Sold (not open market) | — |
| Sep 2, 2026 | Lenaic Nathanael Teyssedou (Officer) | Bought (not open market) | — |
| Sep 2, 2026 | Lenaic Nathanael Teyssedou (Officer) | Sold (not open market) | — |
| Sep 2, 2026 | Lenaic Nathanael Teyssedou (Officer) | Bought (not open market) | — |
| Sep 2, 2026 | Lenaic Nathanael Teyssedou (Officer) | Sold (not open market) | — |
| Sep 2, 2026 | Lenaic Nathanael Teyssedou (Officer) | Bought (not open market) | — |
| Sep 2, 2026 | Isaac Manke (Director) | Bought (not open market) | — |
| Sep 2, 2026 | Jason Raleigh Nunn (Director) | Sold (not open market) | — |
| Sep 2, 2026 | Jason Raleigh Nunn (Director) | Bought (not open market) | — |
| Sep 2, 2026 | Jason Raleigh Nunn (Director) | Sold (not open market) | — |
| Sep 2, 2026 | Jason Raleigh Nunn (Director) | Bought (not open market) | — |
| Sep 2, 2026 | Mikhail Kalinichev (Officer) | Sold (not open market) | — |
| Sep 2, 2026 | Mikhail Kalinichev (Officer) | Bought (not open market) | — |
| Sep 2, 2026 | Mikhail Kalinichev (Officer) | Sold (not open market) | — |
| Sep 2, 2026 | Mikhail Kalinichev (Officer) | Bought (not open market) | — |
Who's trading ADXN
- Timothy Mark Dyer, CEO: other filings, last Sep 2, 2026
- Raymond George Hill, Director: other filings, last Sep 2, 2026
- Mikhail Kalinichev, Officer: other filings, last Sep 2, 2026
- Vincent Michael Lawton, Director: other filings, last Sep 2, 2026
- Isaac Manke, Director: other filings, last Sep 2, 2026
- Roger Mills, C-suite exec: other filings, last Sep 2, 2026
- Jason Raleigh Nunn, Director: other filings, last Sep 2, 2026
- Lenaic Nathanael Teyssedou, Officer: other filings, last Sep 2, 2026
Get free alerts when an insider at Addex Therapeutics Ltd files a new trade →